/Investor DB

Artis Ventures — 2023 Investments

9 investments dated 2023 · listed companies and verified rows first · show all

Affect Therapeuticsaffecttherapeutics.comin𝕏Jul 2023 · $16M✓ verified

Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.

Digital HealthHealthtechMental HealthNew York, US

Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in

BoardKevin Ryan(Director)inJeff Rinehart(Director)in

Co-investorsCity LightAlleyCorpAcumen AmericaGaingelsKapor CapitalLifeArc Ventures+4 more

OverT Bioovert.bioinSeed · Apr 2023 · $16M

Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.

AI & Machine LearningBiotechMedical DevicesNew York, US

Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Co-Founder)inMat Legut(Co-Founder and CEO)in

Board seatVasudev Bailey· per SEC Form D

Co-investorsCivilization Ventures Management, LlcFusionGaingelsHAWKTAILWingAlexandria+2 more

Ekoeko.inin𝕏Feb 2023 · $65M

Eko provides digital banking and financial services to underserved populations in India through a network of merchant business correspondents and an open API platform.

B2B MarketplacesDeveloper ToolsFintechSaaS

Abhinav(Co-founder)Abhishek(Co-founder)

Co-investorsCreation Investments Capital ManagementQuesta CapitalDigiTx Partners LLCHighland Capital PartnersLG Technology VenturesNTT Venture Capital

Ekoeko.comFeb 2023 · $65M

Eko provides AI-driven tools to generate customizable lifestyle imagery and graphics for e-commerce from a single product capture, enabling businesses to create varied assets without additional photo shoots.

AdTechAI & Machine LearningE-commerceRetail Tech

Yoni Bloch(Founder)

Co-investorsBetter Ventures Central LlcMarkerAgaeti VenturesDigiTx Partners LLCEast VenturesHighland Capital Partners+7 more

Inceptiveinceptive.lifeinSep 2023

Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.

AI & Machine LearningBiotechMedical DevicesPalo Alto, US

Jakob Uszkoreit(Founder)inKevin Heyries(Executive Officer)inDiana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)inJakob Uszkoreit Rhiju Das(Founder)Rhiju Das(Founder)

Co-investorsAndreessen HorowitzObvious VenturesS32Section 32NVenturesNVIDIA

Mytosmytos.bioin𝕏Sep 2023

Mytos builds robotic systems that automate the manufacturing of human cells, converting input stem cells into specific cell types such as neurons and heart cells over multiple weeks.

Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB

Ali Afshar(CEO)inIgnacio Willats(Founder)inHenry Miskin(Developer)James Cunningham(Hardware Design Engineer)Jack Owen(Operations)Sam O'Mahony(Senior Electronics Engineer)

Co-investorsY CombinatorAcequia Capital (AceCap)Deep Science VenturesEmles Venture PartnersIQ CapitalJude Gomila+12 more

Ozlo Sleepozlosleep.comin𝕏Series A · Aug 2023 · $10M

Ozlo manufactures sleep wellness products including blackout sleep masks and audio devices designed to improve sleep quality through light and sound control.

ConsumerHardwareWellness & Fitness

Co-investorsLifeArc VenturesWSS

Range Biotechnologiesrange.bioinSeed · Jun 2023 · $5.2M

Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.

BiotechHealthtechMedical Devices

Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Founder)inNicolo Maganzini(Founder)Tom Soh(Founder)

Co-investorsCivilization Ventures Management, LlcFifty YearsHAWKTAILPage One VenturesPear VCFour Cities+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Affect

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.